EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome painting

Sai Harisha Rajanala iD, Romina Ghale, Subhiksha Nandakumar, Kalyani Chadalavada, Gwo-Shu Mary Lee, Konrad H Stopsack, Yu Chen, Gouri J Nanjangud, Goutam Chakraborty, Philip W Kantoff

PLOS ONE · 29.04.2024 · 19 (4) · e0301989

DOI: 10.1371/journal.pone.0301989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 29.04.2024. Verfasst von Sai Harisha Rajanala und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America. Hauptthemen laut MEDLINE: Chromosomes, Human, Y, Chromosome Painting, Neoplasm Metastasis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH/NCI Cancer Center Support Grant, DOD Prostate Cancer Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Somatic Y chromosome loss in hematopoietic cells is associated with higher mortality in men. However, the status of the Y chromosome in cancer tissue is not fully known due to technical limitations, such as difficulties in labelling and sequencing DNA from the Y chromosome. We have developed a system to quantify Y chromosome gain or loss in patient-derived prostate cancer organoids. Using our system, we observed Y chromosome loss in 4 of the 13 (31%) patient-derived metastatic castration-resistant prostate cancer (mCRPC) organoids; interestingly, loss of Yq (long arm of the Y chromosome) was seen in 38% of patient-derived organoids. Additionally, potential associations were observed between mCRPC and Y chromosome nullisomy. The prevalence of Y chromosome loss was similar in primary and metastatic tissue, suggesting that Y chromosome loss is an early event in prostate cancer evolution and may not a result of drug resistance or organoid derivation. This study reports quantification of Y chromosome loss and gain in primary and metastatic prostate cancer tissue and lays the groundwork for further studies investigating the clinical relevance of Y chromosome loss or gain in mCRPC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chromosomes, Human, YChromosome PaintingNeoplasm MetastasisMaleHumansProstatic NeoplasmsProstatic Neoplasms, Castration-ResistantOrganoidsChromosome Deletion

Autor:innen und Institutionen

  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Molecular Cytogenetics Core, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Masacheussets, United States of America.
  • Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Departments of Oncological Sciences Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Tisch Cancer Institute; Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.

ORCID-Profile: Sai Harisha Rajanala

Förderung

  • NCI NIH HHS
  • NIH/NCI Cancer Center Support Grant
  • DOD Prostate Cancer Research Program
  • DOD Early Investigator Research Award
  • Prostate Cancer Foundation
  • NIH/NCI SPORE grant
  • New York State Prostate Cancer Pilot Project grant
  • National Institute of Health

Zitieren

APA

Rajanala, S. H., Ghale, R., Nandakumar, S., Chadalavada, K., Lee, G. M., Stopsack, K. H., Chen, Y., Nanjangud, G. J., Chakraborty, G., & Kantoff, P. W. (2024). Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome painting. PLOS ONE, 19(4), e0301989. https://doi.org/10.1371/journal.pone.0301989

Vancouver

Rajanala SH, Ghale R, Nandakumar S, Chadalavada K, Lee GM, Stopsack KH, et al. Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome painting. PLOS ONE. 2024;19(4):e0301989. doi:10.1371/journal.pone.0301989

BibTeX
@article{Rajanala2024,
  author = {Rajanala, Sai Harisha and Ghale, Romina and Nandakumar, Subhiksha and Chadalavada, Kalyani and Lee, Gwo-Shu Mary and Stopsack, Konrad H and Chen, Yu and Nanjangud, Gouri J and Chakraborty, Goutam and Kantoff, Philip W},
  title = {Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome painting},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {4},
  pages = {e0301989},
  doi = {10.1371/journal.pone.0301989}
}
Kostenlos starten →